Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Other*
-
Issuer Symbol
-
ANRO on NYSE
There are no Buy or Sell transactions made by Apeiron Investment Group Ltd. since 12 Mar 2025
Holdings reported by Apeiron Investment Group Ltd. for Alto Neuroscience, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
674,658 |
|
|
06 Feb 2024 |
By Apeiron Presight Capital Fund II, L.P.( |
|
|
| Common Stock |
251,881 |
|
|
06 Feb 2024 |
Direct |
|
|
| Series A Preferred Stock |
0 |
|
|
06 Feb 2024 |
By Apeiron Presight Capital Fund II, L.P. |
Common Stock |
|
| Series A Preferred Stock |
0 |
|
|
06 Feb 2024 |
Direct |
Common Stock |
|
| Series B Preferred Stock |
0 |
|
|
06 Feb 2024 |
By Apeiron Presight Capital Fund II, L.P. |
Common Stock |
|
| Warrants to Purchase Series A Preferred Stock |
0 |
|
|
06 Feb 2024 |
Direct |
Common Stock |
|
Transactions reported by Apeiron Investment Group Ltd. for Alto Neuroscience, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.